NIKA PHARMACEUTICALS, INC. Net Change in Cash
NIKA PHARMACEUTICALS, INC. (NIKA) reported Net Change in Cash of $1.04 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-08-10
- NIKA PHARMACEUTICALS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2026-03-31 was -$359.00.
- NIKA PHARMACEUTICALS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was -$17.05K, a 216.03% decline year-over-year.
- NIKA PHARMACEUTICALS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was $14.70K, a 308.87% increase year-over-year.
- NIKA PHARMACEUTICALS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was $3.60K.
- NIKA PHARMACEUTICALS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2025 was -$194.00.
- NIKA PHARMACEUTICALS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was -$17.51K, a 193.49% decline from fiscal 2023.
- NIKA PHARMACEUTICALS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was $18.73K, a 3928.39% increase from fiscal 2022.
- NIKA PHARMACEUTICALS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was $465.00.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.04K 10-Q · filed 2026-08-10 | |||||
| 2026-03-31 | -$359.00 10-Q · filed 2026-05-12 | |||||
| 2025-12-31 | -$194.00 10-K · filed 2026-03-25 | |||||
| 2025-09-30 | $4.20K 10-Q · filed 2025-11-07 | |||||
| 2025-06-30 | $13.53K 10-Q · filed 2026-08-10 | |||||
| 2025-03-31 | -$17.05K 10-Q · filed 2026-05-12 | $17.05K 10-Q · filed 2025-05-13 | ||||
| 2024-12-31 | -$17.51K 10-K · filed 2026-03-25 | |||||
| 2024-09-30 | -$18.21K 10-Q · filed 2025-11-07 | |||||
| 2024-06-30 | -$14.84K 10-Q · filed 2025-08-14 | -$12.11K 10-Q · filed 2024-09-18 | ||||
| 2024-03-31 | $14.70K 10-Q · filed 2025-05-13 | $4.87K 10-Q · filed 2024-05-28 | ||||
| 2023-12-31 | $18.73K 10-K · filed 2025-03-31 | |||||
| 2023-09-30 | $10.05K 10-Q · filed 2024-11-12 | |||||
| 2023-06-30 | $10.19K 10-Q/A · filed 2024-11-01 | |||||
| 2023-03-31 | $3.60K 10-Q · filed 2024-05-28 | |||||
| 2022-12-31 | $465.00 10-K · filed 2024-04-01 | |||||
| 2022-09-30 | $3.52K 10-Q · filed 2023-10-31 | |||||
| 2022-06-30 | $8.15K 10-Q · filed 2023-08-21 | |||||
| 2022-03-31 | -$316.00 10-Q · filed 2023-05-15 | |||||
| 2021-12-31 | -$1.21K 10-K · filed 2023-04-10 | |||||
| 2021-09-30 | $88.00 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | -$1.21K 10-Q/A · filed 2022-11-07 | |||||
| 2021-03-31 | -$254.00 10-Q · filed 2022-05-12 | |||||
| 2020-12-31 | $1.61K 10-K · filed 2021-03-24 |